migraines

Biohaven's orally dissolving tablet meets in Phase III for acute migraine
BioCentury
Mon, 12/3/18 - 06:01 pm
Biohaven
migraines
clinical trials
BHV3000-303
Biotech Eli Lilly files for FDA approval of migraine drug lasmiditan
Fierce Biotech
Wed, 11/14/18 - 04:50 pm
Eli Lilly
migraines
FDA
Lasmiditan
Teva slumps after Express Scripts funds migraine rivals in US
Pharmaforum
Thu, 10/18/18 - 11:28 am
PBMs
Teva Pharmaceutical
migraines
Ajovy
Express Scripts
Eli Lilly
Amgen
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Yahoo/Reuters
Wed, 10/17/18 - 09:22 am
Express Scripts
PBMs
migraines
Eli Lilly
Amgen
Teva Pharmaceutical
Emgality
Aimovig
Ajovy
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
Fri, 09/28/18 - 12:32 pm
migraines
Eli Lilly
Emgality
Teva Pharmaceutical
Ajovy
Amgen
Novartis
Aimovig
Lilly’s Emgality nabs third-to-market migraine nod, but aims to be 'treatment of choice' in CGRP
Fierce Pharma
Thu, 09/27/18 - 11:25 pm
Eli Lilly
Emgality
migraines
The worst seems over for Teva
GoinPharma
Tue, 09/18/18 - 10:18 pm
Teva Pharmaceutical
Ajovy
migraines
Teva wins much-needed US approval of migraine drug
Biopharma Dive
Sat, 09/15/18 - 12:09 am
Ajovy
Teva Pharmaceutical
migraines
Aimovig launch bolsters hopes for blockbuster sales
Biopharma Dive
Tue, 08/21/18 - 10:06 am
Aimovig
Amgen
Novartis
migraines
Teva confident migraine drug will launch this year despite new manufacturing woes
Biopharma Dive
Tue, 08/7/18 - 08:45 pm
Teva Pharmaceutical
fremanezumab
migraines
Amgen's new migraine drug hits insurance hurdles
Reuters
Thu, 07/26/18 - 07:41 pm
Amgen
migraines
Aimovig
insurers
Prior authorization limits would be 'reasonable' for CGRP drugs, ICER says
Biopharma Dive
Thu, 07/5/18 - 07:44 pm
insurers
ICER
migraines
CGRP
coverage limits
Amgen, Novartis 'overwhelmed' by early interest in migraine drug Aimovig: expert
Fierce Pharma
Wed, 07/4/18 - 10:01 am
migraines
Amgen
Novartis
Aimovig
Impel NeuroPharma readies trial for intranasal drug-device migraine treatment
Drug Delivery Business News
Fri, 06/22/18 - 07:50 pm
Impel NeuroPharma
FDA
INP104
migraines
intra-nasal drug delivery
Teva to Discontinue Trial of Fremanezumab in Chronic Cluster Headache
CP Wire
Fri, 06/15/18 - 09:16 am
Teva Pharmaceutical
fremanezumab
cluster headaches
migraines
Allergan's Migraine Prevention Drug Meets Primary Endpoints in Ph Iib/III Study
CP Wire
Mon, 06/11/18 - 09:15 am
migraines
Allergan
atogepant
Migraine Breakthrough: Not So Fast
Forbes
Wed, 06/6/18 - 09:49 pm
Amgen
Novartis
Aimovig
migraines
adults
monoclonal antibodies
Thanks to lower-than-expected price, ICER backs Amgen's Aimovig—but only after other meds fail
Fierce Pharma
Fri, 06/1/18 - 11:40 am
Amgen
ICER
Aimovig
migraines
Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst
Fierce Pharma
Tue, 05/22/18 - 06:06 pm
Amgen
FDA
Aimovig
migraines
Prolia
Migraine prevention drug could be worth $1 to $2 billion over next five years: Wall Street analyst
CNBC
Sat, 05/19/18 - 11:30 am
migraines
Amgen
Novartis
Aimovig

Pages